Jefferies (NYSE:JEF) analyst Brian Tanquilut maintained a Buy rating on AdaptHealth (NASDAQ:AHCO) on Wednesday, setting a price target of $48, which is approximately 74.80% above the present share price of $27.46.
Tanquilut expects AdaptHealth to post earnings per share (EPS) of -$0.04 for the third quarter of 2021.
The current consensus among 8 TipRanks analysts is for a Strong Buy rating of shares in AdaptHealth, with an average price target of $41.75.
The analysts price targets range from a high of $50 to a low of $30.
In its latest earnings report, released on 03/31/2021, the company reported a quarterly revenue of $482.12 million and a net profit of $15.41 million. The company's market cap is $3.55 billion.
According to TipRanks.com, Jefferies analyst Brian Tanquilut is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 8.8% and a 59.29% success rate.
AdaptHealth Corp. provides medical products for both rental and sale. It focuses on respiratory and/or mobility equipment, including CPAP sleep equipment, oxygen equipment, wheelchairs, walkers, and hospital beds. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.